Description
The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facility capable of manufacturing products such as cell culture media, cell separation products and ancillary reagents.
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $22,500,000 at start, $22,500,000 after amendment #3 (+$0).
- #02022-01-16$22,500,000
- #12019-07-23$22,500,000
- #22020-07-14$22,500,000
- #32022-01-16$22,500,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2022-01-16 | $22,500,000 | — | The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facilit… |
| #1 amendment | 2019-07-23 | $22,500,000 | +$0 | The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facilit… |
| #2 amendment | 2020-07-14 | $22,500,000 | +$0 | The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facilit… |
| #3 amendment | 2022-01-16 | $22,500,000 | +$0 | The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facilit… |
Related records · 10
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 135714426)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2025-2026-Q4-515888 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund Contributions | $2,829,286 | FY2026 |
| 033-2024-2025-Q4-819532 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream2- Growth | $49,900,000 | FY2025 |
| 172-2020-2021-Q2-952647 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $500,000 | FY2021 |
| GC-WD-DEO-2019-2020-Q2-24 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Regional Economic Growth through Innovation | $5,000,000 | FY2020 |
| GC-WD-DEO-2020-2021-Q1-787 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Western Diversification Program | $946,560 | FY2015 |
Other recipients funded under "SIF Stream3- Attraction" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q4-820215 | IBM Canada Limited - IBM Canada Ltée | FY2025 | $210,000,000 | FY2025 |
| 033-2024-2025-Q3-514896 | Dow Chemical Canada ULC | FY2025 | $400,000,000 | FY2025 |
| 033-2024-2025-Q1-820057 | Aspect Biosystems Ltd. | FY2025 | $49,000,000 | FY2025 |
| 033-2024-2025-Q3-819849 | Ericsson Canada Inc. | FY2025 | $79,100,000 | FY2025 |
| 033-2024-2025-Q1-820155 | Heidelberg Materials Canada Limited | FY2025 | $49,000,000 | FY2025 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2017-2018-Q4-810905 · retrieved 2026-11-12.